GBA1 and Parkinson disease: Sporadic PD patients also have altered levels of glucosylceramide and ceramide, the substrate and product of GCase enzyme activity (Mielke et al., 2013; Guedes et al., 2017), further supporting the observation that GBA enzymatic dysfunction is not a prerequisite for ceramide accumulation.